ImmuCell

Yahoo Finance • 20 days ago

ImmuCell Q1 Earnings Call Highlights

Key Points Interested in ImmuCell Corporation? Here are five stocks we like better. ImmuCell posted a record Q1 2026, with product sales of about $10.4 million, up 28.4% year over year, and net income rising 34% to $1.9 million. Gross mar... Full story

Yahoo Finance • 3 months ago

ImmuCell outlines plan to boost First Defense capacity to 5–6M units while strengthening U.S. market share

Earnings Call Insights: ImmuCell Corporation (ICCC) Q4 2025 MANAGEMENT VIEW * P. F. Te Boekhorst, President and CEO, opened by highlighting a successful year, including hiring a new management team, expanding manufacturing capacity, re... Full story

Yahoo Finance • 3 months ago

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity,... Full story

Yahoo Finance • 5 months ago

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced th... Full story

Yahoo Finance • 7 months ago

ImmuCell GAAP EPS of -$0.02, revenue of $5.50M

* ImmuCell press release [https://seekingalpha.com/pr/20307319-immucell-announces-unaudited-financial-results-for-the-quarter-ended-september-30-2025] (ICCC [https://seekingalpha.com/symbol/ICCC]): Q3 GAAP EPS of -$0.02. * Revenue of $... Full story

Yahoo Finance • 7 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 7 months ago

ImmuCell Announces Onboarding of New CEO and Related Management Changes

PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 8 months ago

ImmuCell announces preliminary sales results for Q3

ImmuCell Corporation (NASDAQ:ICCC [https://seekingalpha.com/symbol/ICCC]) announced on Tuesday preliminary, unaudited sales results for the third quarter of 2025. Preliminary, Unaudited Total Sales Results: 2025 2024 ($ Decrease) $ In... Full story

Yahoo Finance • 8 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 8 months ago

ImmuCell Announces Selection of its Next President and CEO

PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products t... Full story

Yahoo Finance • 10 months ago

ImmuCell outlines cautious H2 outlook as capacity expansion supports First Defense suite

Earnings Call Insights: ImmuCell Corporation (ICCC) Q2 2025 MANAGEMENT VIEW * Michael F. Brigham, President and CEO, stated that ImmuCell is “in the midst of a very positive transition,” having completed its investment to increase prod... Full story

Yahoo Finance • 10 months ago

ImmuCell Announces Bank Debt Refinancing

PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 11 months ago

ImmuCell reports 18% sales growth in Q2 2025

PORTLAND, Maine - ImmuCell Corporation (NASDAQ:ICCC) reported preliminary, unaudited sales of $6.4 million for the second quarter of 2025, representing an 18% increase compared to the same period last year, according to a company press rel... Full story

Yahoo Finance • 11 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 12 months ago

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • last year

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products t... Full story

Yahoo Finance • last year

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products t... Full story

Yahoo Finance • last year

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • last year

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

PORTLAND, Maine, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 3 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story